Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $2.26 Million - $3.69 Million
-10,000 Reduced 18.05%
45,400 $11.5 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $2.22 Million - $4.84 Million
-10,000 Reduced 15.29%
55,400 $21.3 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $2.94 Million - $5.31 Million
-22,600 Reduced 25.68%
65,400 $15.4 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $16.5 Million - $28.1 Million
-151,000 Reduced 63.18%
88,000 $11.5 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $13.7 Million - $35.5 Million
209,000 Added 696.67%
239,000 $25 Million
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $815,100 - $1.42 Million
-15,000 Reduced 33.33%
30,000 $2.12 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $593,400 - $1.6 Million
20,000 Added 80.0%
45,000 $2.89 Million
Q1 2020

May 12, 2020

BUY
$17.78 - $31.58 $444,500 - $789,500
25,000 New
25,000 $749,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.